How do I hire a fractional head of revenue for a biotech company in 2027?
Direct Answer
Biotech revenue leadership in 2027 is not a standard SaaS role. Your buyers are PhDs, lab directors, and procurement committees bound by institutional review boards and multi-year budget cycles. A fractional head of revenue (often called a fractional CRO or VP of Revenue) brings the strategic framework without the full-time overhead. Expect to pay $8,000–$18,000/month for 10–20 days per month of hands-on work, with the lower end for early-stage companies needing strategic planning and the higher end for companies requiring active pipeline management, team coaching, and direct deal support. Equity or performance bonuses are common but should be tied to specific milestones like closing a first reference account or hitting a revenue target. The engagement should have a defined duration (typically 6–12 months) with a clear transition plan to a full-time hire or an extended fractional arrangement.
Why Fractional Revenue Leadership Works for Biotech
Biotech companies face a unique revenue challenge: long sales cycles, high-ticket deals, and buyers who are scientifically trained and risk-averse. A full-time VP of Sales might spend months learning the product and regulatory market. A fractional head of revenue, if they already have biotech domain experience, can start adding value in weeks. They bring a network of existing relationships with key opinion leaders (KOLs), lab managers, and procurement officers — relationships that take years to build.
The fractional model also allows you to test leadership fit before committing to a full-time hire. Biotech startups often pivot their commercial strategy as they move from research grants to commercial sales. A fractional leader can adapt quickly without the emotional and financial cost of a full-time hire that doesn't work out.
What to Look for in a Biotech Fractional CRO
Domain experience is non-negotiable. Look for someone who has sold to academic labs, biotech startups, or large pharma companies. They should understand regulatory pathways (FDA, EMA, GMP, GLP) and how they affect sales cycles. They should know the difference between selling a reagent, an instrument, and a service contract — each has a different buyer, budget, and timeline.
Scientific fluency matters more than sales methodology. A fractional CRO who can discuss assay validation, cell line development, or clinical trial phases will earn trust faster than one who only talks about pipeline velocity. They don't need a PhD, but they need to speak the language.
Network is a force multiplier. A fractional leader who already knows the key decision-makers at 10–20 target accounts can compress a 12-month sales cycle into 4 months. Ask for specific examples of relationships they have in your sub-sector (e.g., immuno-oncology, gene therapy, diagnostics).
How to Structure the Engagement
A fractional CRO engagement should have clear deliverables and defined milestones. Do not hire for "help with growth." Instead, specify: "Build a sales playbook for our new diagnostic kit targeting hospital labs" or "Close our first three reference accounts in the academic research segment."
Time commitment should match the scope. Strategic planning might require 10 days per month. Active deal support and team coaching might require 20 days. Be honest about how much time you need — under-scoping leads to frustration.
Payment structure can be monthly retainer, milestone-based, or a hybrid. Milestone-based (e.g., $X for first signed contract, $Y for hitting $Z in pipeline) aligns incentives but requires clear definitions of what constitutes a "closed deal" (e.g., signed contract vs. purchase order vs. first payment).
Off-ramp is critical. Agree upfront on the duration (6–12 months typical) and what success looks like. If the engagement works, you can extend or convert to full-time. If not, you end cleanly with no hard feelings.
Common Mistakes to Avoid
Hiring a generalist. A fractional CRO who has only sold SaaS subscriptions will fail in biotech. The sales cycle, buyer personas, and compliance requirements are fundamentally different. You need someone who has been in the room with a lab director who asks about limit of detection or cross-reactivity.
Under-scoping the time commitment. Biotech deals require relationship-building over months, not cold outreach. If you only budget 5 days per month, the fractional CRO will spend all their time on admin and none on actual selling. Be realistic about the effort required.
Ignoring cultural fit. Biotech companies often have a research-driven culture that values evidence over hype. A fractional CRO who uses aggressive sales tactics will clash with your team and damage your reputation. Look for someone who can collaborate with your scientific founders, not override them.
Skipping the legal review. Biotech sales often involve confidentiality agreements, material transfer agreements, and regulatory compliance. Make sure your fractional CRO understands these legal constructs and has experience working with your legal team.
FAQ
How do I know if I need a fractional CRO vs. a full-time VP of Sales? If your revenue is below $5M ARR and you are still validating product-market fit, a fractional CRO is usually the better choice. Above $5M ARR, with a growing team and repeatable sales process, a full-time hire may justify the cost. The key question: can you afford to spend 3–6 months recruiting and onboarding a full-time leader, or do you need revenue results now?
What is the typical contract duration for a fractional CRO in biotech? Most engagements run 6–12 months, with a 30-day notice clause for early termination. Some companies extend to 18 months if the fractional leader is driving strong results and a full-time hire is not yet justified.
How do I vet a fractional CRO's biotech experience? Ask for specific examples: what products did they sell, to whom, and what was the sales cycle length? Request references from biotech companies, not just any B2B firm. Look for evidence of scientific literacy — can they discuss your product's technology without needing a glossary?
Can a fractional CRO work remotely for a biotech company? Yes, but with caveats. Biotech sales often require in-person meetings with lab directors and procurement teams. A remote fractional CRO should be willing to travel for key meetings. Hybrid arrangements (remote strategy + on-site deal support) are common and effective.
What tools should a fractional CRO use for biotech sales? Standard tools like Salesforce or HubSpot for CRM, Outreach or Salesloft for sales engagement, Gong for call coaching, and Clari for revenue forecasting are common. However, biotech-specific tools like Veeva (for life sciences CRM) or Zymewire (for biotech prospecting) may be relevant. The fractional CRO should be tool-agnostic and adapt to your stack.
How do I transition from a fractional CRO to a full-time hire? Plan the transition in your initial contract. The fractional CRO should document processes, train your team, and hand off key relationships. Some fractional leaders can convert to full-time if both parties agree, but it's better to plan for a clean handoff to avoid dependency.
What if the fractional CRO doesn't deliver results? Your contract should include a 30-day notice period and clear milestones. If results are not materializing, you can end the engagement quickly. The low commitment of a fractional arrangement is its main advantage — you are not stuck with a bad hire for months.